Results 61 to 70 of about 51,024 (230)

Pruritus Is Frequent and Persistent and Impacts Quality of Life Among Patients With Primary Sclerosing Cholangitis

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Among 200 patients with primary sclerosing cholangitis, 38% reported moderate to severe pruritus in the past 6 months. During 6 months of follow up, pruritus severity fluctuated significantly. Pruritus severity was linked to worse colitis activity and lower quality of life.
Richard Dean   +16 more
wiley   +1 more source

Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report [PDF]

open access: yes, 2016
Warfarin therapy is associated with many drug interactions that may cause a significant alteration in its anticoagulant effect. Rifampin is a widely used antimicrobial that has major interactions with several medications including warfarin due to its ...
Amr Mohamed Fahmi   +5 more
core   +1 more source

Doses of rifampin by weight band.

open access: yes, 2023
Doses of rifampin by weight band.
Victoria Cook (14559272)   +12 more
core   +1 more source

Stability of Rifampin in Dimethylsulfoxide [PDF]

open access: yesApplied Microbiology, 1969
Stock solutions of rifampin remain stable in dimethylsulfoxide for at least 8 months.
A G, Karlson, J A, Ulrich
openaire   +2 more sources

Cleanse, Perfuse, Retain (CPR) Protocol for Management of Postoperative Infections With d‐PTFE Membranes: Clinical Reports of Three Cases

open access: yesJournal of Esthetic and Restorative Dentistry, EarlyView.
ABSTRACT Objective Postoperative infection is a serious complication of bone augmentation procedures, potentially resulting in graft failure, basal bone resorption, and spread of infection to adjacent anatomic spaces. This paper introduces the CPR (Cleanse, Perfuse, and Retain) protocol and illustrates its clinical application in the management of low‐
Istvan A. Urban   +2 more
wiley   +1 more source

Plant‐Based Production of Human Major Histocompatibility Complex Class II Molecules

open access: yesPlant Biotechnology Journal, EarlyView.
ABSTRACT Major histocompatibility complex class II (MHC II) protein triggers adaptive immune responses by presenting antigens on antigen‐presenting cells (APCs) to be recognised by CD4+ T cells. Recombinant MHC II proteins are effective for the analysis of peptide‐binding interaction, detection of antigen‐specific T‐cells and clinical testing for donor‐
Abdelaziz Ramadan   +8 more
wiley   +1 more source

Treatment Patterns in Pediatric Hidradenitis Suppurativa: Time to Treatment Initiation, Initial Treatment, and Time to Switching

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background Hidradenitis suppurativa (HS) causes significant morbidity in children. Treatment patterns across sex, race, and ethnicity in pediatric HS have not been thoroughly evaluated. We aim to characterize treatment patterns in pediatric HS, including (1) time to treatment initiation, (2) first prescribed HS treatment, and (3) time to ...
Shaliz Aflatooni   +7 more
wiley   +1 more source

Rifampin-Fluconazole Interaction in Critically ILL Patients

open access: yes, 1995
Objective: To report the influence of rifampin coadministration on the pharmacokinetics of fluconazole in 2 critically ill patients. Case Summaries: The pharmacokinetics of fluconazole are reported in 5 patients in the intensive care unit (ICU), 2 of ...
Helen M Crowe   +3 more
core   +1 more source

Prevalence of Antimicrobial Use in Small Animal Dermatology Referral Practices in the United States

open access: yesVeterinary Dermatology, EarlyView.
ABSTRACT Background Antimicrobial resistance is a critical global health concern driven by antimicrobial use. Dermatological conditions are common reasons for antimicrobial prescriptions in small animal practice, yet data on prescribing patterns in veterinary dermatology referral settings are lacking. Hypothesis/Objectives To characterise the frequency,
Domenico Santoro   +2 more
wiley   +1 more source

Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations

open access: yes, 2001
Rifampin is the most potent drug used in the treatment of disease due to Mycobacterium kansasii. A 69-bp fragment of rpoB, the gene that encodes the beta subunit of the bacterial RNA polymerase, was sequenced and found to be identical in five rifampin ...
Klein, J L, Brown, T J, French, G L
core   +1 more source

Home - About - Disclaimer - Privacy